Total anomalous pulmonary venous return (TAPVR) is a rare congenital heart defect in which all pulmonary veins abnormally drain into a systemic venous structure or directly into the right atrium, instead of the left atrium. This anomaly prevents the normal return of oxygenated blood from the lungs to the left heart, leading to a complete mixing of arterial and venous blood and resulting in a hypoxic systemic circulation.
TAPVR accounts for approximately 1–2% of all congenital heart diseases, with an estimated incidence of 1 case per 15,000–25,000 live births. It is frequently associated with atrial septal defects, whose presence is essential for survival, as it allows oxygenated blood to pass from the right atrium to the left atrium.
Based on the site of the anomalous connection of the pulmonary veins, TAPVR is classified into four main anatomical types:
Early diagnosis and prompt surgical intervention are critical to prevent severe complications and improve prognosis in newborns affected by this complex malformation.
Total anomalous pulmonary venous return results from an embryological failure in the connection between the pulmonary veins and the left atrium. Normally, during fetal development, a primitive pulmonary venous plexus establishes a connection with the wall of the left atrium, forming the normal drainage pattern of the pulmonary veins. If this connection fails, the pulmonary veins maintain their primitive communications with embryonic systemic venous systems (superior vena cava, azygos vein, coronary sinus, portal vein), giving rise to TAPVR.
This anomaly represents a definite and isolated etiological cause of the disease. However, in some cases, TAPVR occurs in association with complex genetic anomalies such as trisomy 21 or heterotaxy syndrome, suggesting a possible role of genetic or epigenetic predisposition. Among the modifiable risk factors are teratogenic exposures during pregnancy, including alcohol consumption, certain antiepileptic drugs, or viral infections, although a definitive causal relationship is not always documented.
From a pathophysiological standpoint, TAPVR leads to a complete mixing of arterial and venous blood in the right atrium or a systemic vein, resulting in chronic systemic hypoxemia. Survival depends on the presence of an interatrial communication that allows oxygenated blood to cross the septum and reach the left atrium and the aorta.
The extent of the right-to-left shunt is determined by the degree of obstruction to pulmonary venous outflow. In non-obstructed forms, the high pulmonary venous return to the right atrium causes volume overload of the right heart and pulmonary overcirculation, progressively leading to congestive heart failure and pulmonary hypertension. In obstructed forms, typically seen in infracardiac TAPVR, there is an acute increase in pulmonary venous pressure, with severe pulmonary congestion, interstitial edema, and profound hypoxia, constituting a neonatal emergency.
Without surgical correction, progressive hemodynamic and respiratory compromise results in a marked reduction of systemic output, leading to hypoxic shock and early death within the first month of life.
The clinical picture of total anomalous pulmonary venous return (TAPVR) largely depends on the anatomical type of the malformation and the presence or absence of pulmonary venous obstruction. Presentation varies from severe forms with early neonatal onset to mild or subclinical forms appearing later in infancy.
The obstructed form, more common in infracardiac TAPVR, constitutes a neonatal emergency. Compression of the anomalous venous pathway by anatomical structures (e.g., diaphragm, liver) impedes blood outflow from the lungs, rapidly increasing capillary pressure and resulting in severe pulmonary edema.
The non-obstructed form, more typically associated with supracardiac and cardiac TAPVR, allows for longer survival but still leads to progressive pulmonary congestion, heart failure, and growth delay if untreated.
During history taking, the following features may be reported in neonates and infants with TAPVR:
On physical examination, signs indicative of pulmonary congestion and heart failure may include:
In the absence of an early diagnosis, TAPVR may initially be misinterpreted as other neonatal conditions with acute respiratory onset, such as hyaline membrane disease, sepsis, complex cyanotic congenital heart disease, or persistent pulmonary hypertension of the newborn. However, resistance to oxygen therapy and the persistence of severe cyanosis with pulmonary edema should always raise suspicion of an obstructed form of TAPVR.
In infants with non-obstructed TAPVR, symptoms are more subtle but progressively worsen, with chronic tachypnea, profuse sweating during feeding, failure to thrive, and recurrent respiratory infections. These features reflect pulmonary overcirculation and right ventricular failure.
Early diagnosis based on integrated evaluation of medical history, physical signs, and symptom progression is essential to promptly initiate appropriate diagnostic testing and treatment, reducing neonatal mortality in the obstructed form and long-term complications of non-obstructed forms.
The diagnosis of total anomalous pulmonary venous return (TAPVR) is based on the integration of clinical data, instrumental findings, and morphological confirmation. Since the obstructed form can rapidly progress to neonatal death, it is essential to recognize suggestive clinical signs early and initiate the most appropriate investigations without delay.
Initial suspicion arises in the presence of central cyanosis unresponsive to oxygen therapy, early signs of respiratory distress, and pulmonary edema in a neonate with relatively preserved arterial blood pressure. The absence of loud pathological murmurs often makes auscultatory diagnosis unhelpful.
Transthoracic echocardiography (TTE) is the cornerstone of diagnosis. In neonates with TAPVR, echocardiographic findings may include:
If the acoustic window is suboptimal or when detailed assessment of the anomalous venous course is needed, transesophageal echocardiography (TEE) or cardiac magnetic resonance imaging (MRI) may provide more accurate morphological and functional information.
Cardiac computed tomography (multislice CT) with contrast is extremely useful in stable patients, as it allows precise three-dimensional reconstruction of pulmonary venous return, enabling accurate identification of the anatomical type (supracardiac, cardiac, infracardiac, or mixed), the presence of obstructions, and the relationships with thoracic structures.
Angiography, once considered the gold standard, is now reserved for selected cases requiring invasive preoperative hemodynamic evaluation or when non-invasive techniques are inconclusive.
Electrocardiography (ECG) in neonates with TAPVR often reveals signs of right-sided chamber hypertrophy and right axis deviation, but is not diagnostic. It may be useful in postoperative follow-up to monitor ventricular pressure load.
Chest radiography can be suggestive in non-obstructed cases. These patients may present with an enlarged, globular heart silhouette and a generalized increase in pulmonary vascular markings. In the supracardiac form, the mediastinal shadow may show a characteristic “snowman” sign, caused by dilation of the innominate vein and anomalous pulmonary veins at the upper mediastinum.
Arterial blood gas analysis typically reveals refractory hypoxemia with or without metabolic acidosis, depending on the degree of obstruction and the efficiency of cardiac compensation.
Finally, continuous pulse oximetry shows persistent desaturation despite oxygen therapy, often below 85%, especially in obstructive forms. This finding, combined with the absence of apparent intracardiac defects on initial evaluation, should always prompt suspicion of TAPVR.
Timely diagnosis, particularly in the obstructed form, is crucial to enable early surgical correction and significantly improve neonatal outcomes.
The treatment of total anomalous pulmonary venous return (TAPVR) is exclusively surgical and must be performed urgently, especially in obstructive forms, which represent a neonatal emergency. Medical therapy provides only temporary support and is never curative.
While awaiting surgery, it is essential to provide adequate hemodynamic and respiratory support to stabilize the newborn:
The surgical procedure involves redirecting pulmonary venous return to the left atrium, creating a direct connection between the pulmonary venous confluence and the anatomical left atrium. The operative technique depends on the anatomical subtype of the malformation:
During surgery, the atrial septal defect is generally closed or reduced in a controlled manner to ensure normal postoperative physiology. It is also critical to ensure that pulmonary venous flow remains unobstructed after the anastomosis, as any residual stenosis constitutes a serious complication.
The postoperative period requires intensive monitoring, with particular attention to:
In experienced centers, operative mortality is currently low (less than 10% in non-obstructed cases), but can rise significantly in obstructed forms, particularly when diagnosis and intervention are delayed. Long-term outcomes are favorable in most patients, although prolonged cardiologic surveillance is required due to the risk of anastomotic stenosis, ventricular dysfunction, or postoperative arrhythmias.
The prognosis of total anomalous pulmonary venous return (TAPVR) critically depends on the anatomical type, presence or absence of pulmonary venous obstruction, and the timeliness of diagnosis and surgical treatment.
In non-obstructed forms, prognosis is generally favorable if surgery is performed within the first weeks of life. In these patients, long-term survival exceeds 90%, with many reaching adulthood with good quality of life and satisfactory cardiac function. Key prognostic factors include postoperative right ventricular function, absence of early complications, and sustained patency of pulmonary venous flow.
Conversely, in obstructed forms, which present in the neonatal period with severe hypoxia and hemodynamic instability, the prognosis is more guarded. Perioperative mortality is higher in these cases, especially when diagnosis and correction are delayed. Nevertheless, even in complex cases, early surgery in specialized centers achieves survival rates above 70–80%.
Major late complications affecting long-term outcomes include:
Therefore, regular cardiologic follow-up is essential, including serial echocardiography, pulmonary function tests, and, in selected cases, cardiac MRI or diagnostic catheterization. In patients with recurrent stenosis or persistent pulmonary hypertension, additional therapeutic strategies may be required, including percutaneous interventions or surgical revision.
Overall, with timely treatment and appropriate follow-up, most patients with surgically corrected TAPVR can lead a normal life without significant functional limitations.
If left untreated, total anomalous pulmonary venous return (TAPVR) has an invariably fatal course. The main complication of unrepaired forms is congestive heart failure associated with severe hypoxemia, especially in obstructed types, rapidly progressing to shock and death within the first weeks of life.
In operated patients, complications may be early or late. Key early postoperative complications include:
Relevant late complications include:
Long-term monitoring is recommended for all patients, even if asymptomatic, to detect complications early and prevent deterioration of cardiac function or the development of irreversible pulmonary hypertension.